Tirzepatide activates a different receptor profile, and your body needs to adapt to the GIP agonism regardless of your GLP-1 experience
Diabetes Epidemiology and Management, 12, 100162
( A ) and ( B ) show a sagittal view showing regions where plasma biomarker concentrations negatively correlate with neurite density index (NDI) values
As a result, it reduces any kind of oxidative damage to the cells
During the first 2 to 4 weeks, you may experience: Nausea : Often most pronounced after meals, typically improving over time Reduced appetite : You may feel full more quickly and have less interest in food Mild abdominal discomfort : Bloating or a feeling of fullness Altered bowel habits : Either constipation or loose stools Fatigue : Some patients report tiredness as their body adjusts These effects are generally mild to moderate and tend to diminish as your body adapts to the medication
Combine water with minerals like sodium, potassium, and magnesium to keep your metabolism working well
